PTJ
IRMD icon

Paul Tudor Jones’s iRadimed IRMD Stock Holding History

Paul Tudor Jones’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.36M Sell
45,626
-26,210
-36% -$2.39M 0.01% 1382
2026
Q1 		$6.91M Buy
71,836
+40,659
+130% +$4.07M 0.01% 965
2025
Q4 		$3.03M Buy
31,177
+21,817
+233% +$1.87M 0.01% 1502
2025
Q3 		$666K Buy
+9,360
New +$624K ﹤0.01% 2531
2025
Q2 		– Sell
-23,467
Closed -$1.23M – 3493
2025
Q1 		$1.23M Sell
23,467
-7,549
-24% -$424K ﹤0.01% 1680
2024
Q4 		$1.71M Buy
31,016
+8,147
+36% +$429K 0.01% 1360
2024
Q3 		$1.15M Buy
22,869
+17,820
+353% +$822K ﹤0.01% 1532
2024
Q2 		$222K Buy
+5,049
New +$215K ﹤0.01% 2123
2024
Q1 		– Sell
-6,963
Closed -$331K – 2479
2023
Q4 		$331K Sell
6,963
-9,390
-57% -$395K ﹤0.01% 1990
2023
Q3 		$726K Buy
16,353
+634
+4% +$29.5K 0.01% 1482
2023
Q2 		$750K Buy
15,719
+6,817
+77% +$307K 0.01% 1480
2023
Q1 		$350K Buy
+8,902
New +$324K 0.01% 1826

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paul Tudor Jones's IRMD Position: Q2 2026 in Review

Paul Tudor Jones reduced its iRadimed (IRMD) stake by 36% in Q2 2026, selling an estimated $2.39M and leaving 45,626 shares worth $4.36M. The position accounts for 0.01% of the portfolio, ranked #1382.

Paul Tudor Jones first reported a position in IRMD in Q1 2023 and has held it in 12 quarters since. The position peaked at $6.91M in Q1 2026. 212 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Paul Tudor Jones held 45,626 shares of iRadimed worth $4.36M as of Q2 2026.
  • Paul Tudor Jones sold 26,210 iRadimed shares in Q2 2026, an estimated $2.39M.
  • iRadimed made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1382 holding.
  • Paul Tudor Jones first reported a position in iRadimed in Q1 2023 and has held it in 12 quarters since.
  • Paul Tudor Jones's iRadimed position peaked at $6.91M in Q1 2026.
  • 212 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.